AstraZeneca-Sputnik V combination demonstrates high immunogenicity profile: RDIF
Preliminary data from the first 20 participants in Azerbaijan show antibodies to the SARS-CoV-2 virus spike protein (S-protein) elicited in 100% of cases
Preliminary data from the first 20 participants in Azerbaijan show antibodies to the SARS-CoV-2 virus spike protein (S-protein) elicited in 100% of cases
Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
Innovative solutions and a deep understanding of the market makes this a unique combination
AstraZeneca, Sinopharm and Moderna were part of the study
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
Subscribe To Our Newsletter & Stay Updated